Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Add Yahoo as a preferred source to see more of our stories on Google. HSP-CAR30 CAR-T therapy offers lasting remission in refractory lymphoma, showing 100% response in early trials. (CREDIT: ...

UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block ...

Viruses attack nearly every living organism on Earth. To do so, they rely on highly specialized proteins that recognize and bind to receptors on the surface of target cells, a molecular arms race that ...

Explore the World ADC Conference highlights on antibody-drug conjugates and their impact on cancer therapy and clinical ...

Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature ...

University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, potentially delaying type 1 diabetes progression in animal models.

Researchers found three master genes that alter brain development in Down syndrome, offering new clues about learning and memory differences.

Long overlooked in the field of musculoskeletal study, the tendon is a highly complex anatomical structure that triggers a dynamic but mysterious cellular response when it's injured. In a new study in ...